Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of 30% Metformin and 2% Nicotinamide Lotion With Kligman Formula in the Treatment of Melasma

NCT05790577 is registered in ClinicalTrials.gov with Ishtiaq Ahmed as lead sponsor.

NCT NCT05790577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05790577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of 30% Metformin and 2% Nicotinamide Lotion With Kligman Formula in the Treatment of Melasma
Lead sponsor
Ishtiaq Ahmed
Phase
Phase 2
Overall status
Completed
Start date
February 1, 2022
Completion date
February 15, 2023
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melasma